CASI Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on CASI Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date CASI Pharmaceuticals Inc Strategy Report
- Understand CASI Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on CASI Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4211476A1 | Application | Procédés de criblage de sang | A61K2039/505; A61P35/00; C07K16/2896; C07K2317/21; C07K2317/33; C07K2317/565; C07K2317/92; G01N2333/70596; G01N2500/10; G01N2800/24; G01N33/80 | July 19, 2023 |
| US20230174529A1 | Application | Crystalline forms and formulations of a vcp/p97 inhibitor | A61K45/06; A61K9/485; A61K9/4858; A61K9/4866; C07B2200/13; C07C309/30; C07D471/04 | June 08, 2023 |
| US20230172936A1 | Application | Vcp/p97 inhibitor for the treatment of cancer | A61K31/439; A61K31/4745; A61K31/475; A61K31/497; A61K31/5025; A61K31/506; A61K31/519; A61K31/5377; A61K31/635; A61K31/69; A61K31/706; A61K31/7068; A61K45/06; A61P35/00; A61P35/02 | June 08, 2023 |
| AU2021338773A1 | Application | Methods of blood screening | A61K2039/505; A61P35/00; C07K16/2896; C07K2317/21; C07K2317/33; C07K2317/565; C07K2317/92; G01N2333/70596; G01N2500/10; G01N2800/24; G01N33/80 | May 25, 2023 |
| KR1020230066404A | Application | 혈액 스크리닝 방법 | A61K2039/505; A61P35/00; C07K16/2896; C07K2317/21; C07K2317/33; C07K2317/565; C07K2317/92; G01N2333/70596; G01N2500/10; G01N2800/24; G01N33/80 | May 15, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer